Santen

Santen Pharmaceutical Co., Ltd. is a global pharmaceutical company based in Osaka, Japan, specializing in eye care and ophthalmology. Founded in 1890, the company initially produced cold medications but shifted its focus to eye care in 1899 with the launch of Daigaku Eye Drops. Santen has a strong history of innovation, including the introduction of Japan’s first plastic eye drop container and the landmark prescription product Mydrin-P in 1962. The company primarily offers prescription ophthalmic pharmaceuticals, which account for over 90% of its sales. Its product range includes treatments for glaucoma, dry eye, and other ocular disorders, as well as various drug delivery systems. Santen invests significantly in research and development, dedicating around 17.2% of its revenue to advancing ophthalmic care. With a commitment to enhancing quality of life through better eye health, Santen aims to be a trusted leader in ophthalmology by 2035.